APA (7th ed.) Citation

Kapoor, R., Deek, M. P., McIntyre, R., Raman, N., Kummerlowe, M., Chen, I., . . . Tran, P. T. (2019). A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA). BMC.

Chicago Style (17th ed.) Citation

Kapoor, Roche, et al. A Phase II Randomized Placebo-controlled Double-blind Study of Salvage Radiation Therapy Plus Placebo Versus SRT Plus Enzalutamide with High-risk PSA-recurrent Prostate Cancer After Radical Prostatectomy (SALV-ENZA). BMC, 2019.

MLA (8th ed.) Citation

Kapoor, Roche, et al. A Phase II Randomized Placebo-controlled Double-blind Study of Salvage Radiation Therapy Plus Placebo Versus SRT Plus Enzalutamide with High-risk PSA-recurrent Prostate Cancer After Radical Prostatectomy (SALV-ENZA). BMC, 2019.